Vinge advises Amasten Fastighets AB (publ) in connection with its public offer to the shareholders of SSM Holding AB (publ) (“SSM”)

The offer consideration consists of shares in Amasten, corresponding to a value of approximately SEK 400 million. Amasten is a property company that manages, develops and builds. The property portfolio consists of 92 percent housing, whereby the remaining area consists of office, retail, industrial and community premises. SSM produces smart, affordable homes with attractive shared spaces close to public transport and the city centre for its target group – tomorrow’s urbanites.

Vinge’s team consists of Jesper Schönbeck, Rikard Lindahl, Malte St Cyr Ohm, Boris Kotur, Clara Sohlberg, Lisa Malmborg and Emil Lindwall (Capital Markets and Public M&A), Johan Wahlbom and Joel Kokko (EU, Competition and Regulatory), Pauline Lagerstrand and Felix Möller (Banking and Finance), Henrik Wastenson (Corporate Tax) as well as Kristofer Larson (Real Estate).


Related

Vinge advised Precise Biometrics

Vinge has advised Precise Biometrics AB in connection with the merger with Fingerprint Cards.
March 27, 2026

Vinge has advised Xspray Pharma in connection with its rights issue

Vinge has advised Xspray Pharma AB (publ) in connection with a rights issue of approximately SEK 83 million before transaction costs, with an over-allotment issue of approximately SEK 30 million.
March 26, 2026

Vinge advises Diamyd Medical in connection with directed issuances of shares and warrants of up to SEK 1,166 million

Vinge advises Diamyd Medical Aktiebolag (“Diamyd Medical”), listed on Nasdaq First North Growth Market, in connection with directed issuances of shares and warrants whereby Diamyd Medical receives gross proceeds of approximately SEK 1,166 million, if all warrants are exercised.
March 25, 2026